Atlas Venture Fund XII, L.P.'s Net Worth
-$3.08 Million
Who is Atlas Venture Fund XII, L.P.?
Atlas Venture Fund XII, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Vigil Neuroscience, Inc., Aerovate Therapeutics, Inc., and Gemini Therapeutics, Inc. /DE.
SEC CIK
Atlas Venture Fund XII, L.P.'s CIK is 0001812049
Past Insider Trading and Trends
2021 was Atlas Venture Fund XII, L.P.'s most active year for acquiring shares with 2 total transactions. Atlas Venture Fund XII, L.P.'s most active month to acquire stocks was the month of June. 2022 was Atlas Venture Fund XII, L.P.'s most active year for disposing of shares, totalling 2 transactions. Atlas Venture Fund XII, L.P.'s most active month to dispose stocks was the month of June. 2021 saw Atlas Venture Fund XII, L.P. paying a total of $7,499,996.00 for 3,103,879 shares, this is the most they've acquired in one year. In 2021 Atlas Venture Fund XII, L.P. cashed out on 7,976,754 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Gemini Therapeutics, Inc. /DE (IRON) Snapshot price: $50.35
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vigil Neuroscience, Inc. (VIGL) Snapshot price: $3.53
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +304.67% | 4.39M |
$14.00 |
—
| 5.84M |
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aerovate Therapeutics, Inc. (AVTE) Snapshot price: $1.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.76% | -310.39K |
—
|
—
| 2.33M |
Scheduled
|
Jul 15
| ||
Form 4
| -15.00% | -465.58K |
—
|
—
| 2.64M |
Scheduled
|
Apr 1
| ||
Form 4
|
∞
| 3.1M |
$14.00 |
—
| 3.1M |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||